Kymera Therapeutics
KYMR
#1949
Rank
โ‚ฌ8.97 B
Marketcap
105,12ย โ‚ฌ
Share price
-3.42%
Change (1 day)
83.31%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): -3,15ย โ‚ฌ

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -3,30ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,35ย โ‚ฌ a decrease over its 2024 EPS that were of -2,71ย โ‚ฌ.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,15ย โ‚ฌ-6.17%
2025-3,35ย โ‚ฌ23.91%
2024-2,71ย โ‚ฌ17.86%
2023-2,30ย โ‚ฌ-12.5%
2022-2,63ย โ‚ฌ39.81%
2021-1,88ย โ‚ฌ22.84%
2020-1,53ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA